Emory University Winship Cancer Institute: Lonial Leads Pivotal Trial Supporting FDA Approval of First CELMoD Therapy for Multiple Myeloma
August 15, 2026
August 15, 2026
ATLANTA, Georgia, Aug. 15 -- Emory University Winship Cancer Institute issued the following news release:
* * *
Lonial leads pivotal trial supporting FDA approval of first CELMoD therapy for multiple myeloma
Results from a pivotal Phase 3 clinical trial led by Sagar Lonial, MD, FACP, FASCO, chief medical officer of Winship Cancer Institute of Emory University, supported accelerated approval by the U.S. Food and Drug Administration of the first therapy in a . . .
* * *
Lonial leads pivotal trial supporting FDA approval of first CELMoD therapy for multiple myeloma
Results from a pivotal Phase 3 clinical trial led by Sagar Lonial, MD, FACP, FASCO, chief medical officer of Winship Cancer Institute of Emory University, supported accelerated approval by the U.S. Food and Drug Administration of the first therapy in a . . .